Entities / Company
Windtree Therapeutics (United States).
company in Philadelphia, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 30
What's happening
Gone quiet
No new reports in 90+ days-
Windtree Therapeutics, a publicly-listed company, has pivoted its focus into a digital treasury, analyzing distressed firms and discussing potential large Ethereum acquisitions.Some support3 reports
-
Windtree Therapeutics will serve as the sourcing partner for Evofem Biosciences, Inc., whose product PHEXXI will be manufactured by a partner in China.Speculative1 report
-
Windtree Therapeutics expects data useful for an end of Phase 2 meeting.Speculative1 report
-
Windtree Therapeutics is seeking revenue generation opportunities within the US market.Speculative1 report
-
Windtree Therapeutics is building a BNB treasury and aims to bring tokenized securities to the BNB Chain.Some support2 reports
-
Windtree Therapeutics signs an agreement to launch a BNB treasury strategy, with Patrick Horsman of Build & Build Corp involved.Some support1 report
-
Windtree Therapeutics pivoted into digital assets, earning the nickname 'BNB MicroStrategy' after providing financing and failing a minimum price requirement.Some support3 reports2 developments inside
-
Windtree Therapeutics focused its treasury strategy on BNB, with Kraken managing the program.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Windtree Therapeutics (United States) this week
News at the entities that move Windtree Therapeutics (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Windtree Therapeutics (United States)
Connections
The 2 strongest of 30, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Windtree Therapeutics' operations and revenue generation are dependent on FDA approval and regulatory oversight.
-
Bank of the Northeast Mentioned together
No evidence provided detailing a relationship between Windtree Therapeutics and Bank of the Northeast.
History
Events by the month they beganJune 2026
8 events- Windtree Therapeutics, a publicly-listed company, has pivoted its focus into a digital treasury, analyzing distressed firms and discussing potential large Ethereum acquisitions.
- Windtree Therapeutics will serve as the sourcing partner for Evofem Biosciences, Inc., whose product PHEXXI will be manufactured by a partner in China.
- Windtree Therapeutics expects data useful for an end of Phase 2 meeting.
- Windtree Therapeutics is seeking revenue generation opportunities within the US market.
- Windtree Therapeutics is building a BNB treasury and aims to bring tokenized securities to the BNB Chain.
- Windtree Therapeutics signs an agreement to launch a BNB treasury strategy, with Patrick Horsman of Build & Build Corp involved.
- Windtree Therapeutics pivoted into digital assets, earning the nickname 'BNB MicroStrategy' after providing financing and failing a minimum price requirement.
- Windtree Therapeutics focused its treasury strategy on BNB, with Kraken managing the program.